The Biggest Announcement in GLP-1 Patient History
The White House announced pricing agreements on November 6th, 2025, that will enable Medicare and Medicaid to cover GLP-1 medications for obesity with a $50 copay. Most-Favored-Nation pricing will be applied to brand-name drugs, and discounted cash prices are anticipated by late…